Does Sepura Plc Offer More Value Than Genus plc & SDL plc After A 24% Rally?

Sepura Plc (LON:SEPU), Genus plc (LON:GNS) and SDL plc (LON:SDL) are under the spotlight.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Stocks with a “tech slant” always attract attention — take Sepura (LSE: SEPU), for instance.

It has risen a lot in the last two months of trade, and there’s reason to believe that its stock could continue to outperform Genus (LSE: GNS) and SDL (LSE: SDL) in weeks ahead.

Here’s my quick take. 

Sepura (Market Cap €400m)

What you are buying: the company designs, develops and supplies digital radio systems, accessories and other related tools. It’s forecast to grow revenues at an astonishing compound annual growth rate (CAGR) of 19% into 2017, which will likely yield rapidly rising earnings and dividends. 

Bullish brokers forecast upside of up to about 30% from its current level of 160p a share. Earlier this week, Panmure’s price target rose to 190p a share from 170p, while at the end of May Liberum said that the business could be worth 202p a share.

I think analysts may well be right. 

Its balance sheet is strong, and based on forward earnings for cash flows and net earnings, its shares could indeed rise from its current level if it keeps up with its current strategy — on 26 May, it completed the acquisition of Teltronic, a €127.5m deal that was announced on 1 May, and contributed to a +24% performance since.

Genus (Market Cap £900m)

What you are buying: This is a biotech company with focus on animal genetics. I am not a big fan of biotech companies: they can deliver huge returns, but that comes at a high risk — Genus fell 30% in 1Q14, for instance, although it has recovered most of its value since. Genus could be added to your wish list now, however.

Its stock is up 13% this year and 40% since June 2014. Admittedly, it doesn’t trade in ‘bargain territory’, one of the reasons being that its forward earnings multiple stands at 28x, while its forward dividend yield is in the region of 1.3%. But if forecasts are correct, Genus may be able to grow earnings per share at 10% a year or more, which would render its stock cheaper, on a relative basis. 

Much of its fortunes hinge on cash returns, in my view; the good news is that Genus has room to boost returns by deploying more capital. 

SDL (Market Cap £330)

What you are buying: SDL offers information management solutions and software applications, a sector where consolidation is on the cards . SDL stock is essentially flat in 2015, and has been looking for direction for a couple of years now. It looks a tad expensive, based on key financial metrics, trading multiples, and in the light of a lowly forward dividend yield. 

Its balance is strong, but core operating margins are not incredibly enticing. I think management would do well to announce a more aggressive corporate strategy with regard to capital allocation — its core free cash flow yield is low, but there’s room for action, if it exploits its balance sheet. 

Until then, investors would do well to give it a pass. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »